Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade

Expression of inhibitors of apoptosis protein (IAP) family members is associated with poor prognosis in cancer patients. Immunity to ML-IAP (livin) and survivin has been well studied in patients with a variety of tumors. XIAP, the most potent inhibitor of apoptosis, is widely expressed in melanoma....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Immunol Immunother
Egile Nagusiak: Zhou, Jun, Li, Jingjing, Guleria, Indira, Chen, Tianqi, Giobbie-Hurder, Anita, Stevens, Jonathan, Gupta, Meghna, Wu, Xinqi, Brennick, Ryan C., Manos, Michael P., Hodi, F. Stephen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6684401/
https://ncbi.nlm.nih.gov/pubmed/31317218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-019-02370-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak